{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:07:55Z","timestamp":1794564475856,"version":"4.9.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021.05460.BD"],"award-info":[{"award-number":["2021.05460.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERC Proof of Concept","award":["899932 (Hyperfoods)"],"award-info":[{"award-number":["899932 (Hyperfoods)"]}]},{"name":"ERC Proof of Concept","award":["899932 (Hyperfoods)"],"award-info":[{"award-number":["899932 (Hyperfoods)"]}]},{"name":"ERC Proof of Concept","award":["899932 (Hyperfoods)"],"award-info":[{"award-number":["899932 (Hyperfoods)"]}]},{"name":"ERC Proof of Concept","award":["899932 (Hyperfoods)"],"award-info":[{"award-number":["899932 (Hyperfoods)"]}]},{"name":"ERC Proof of Concept","award":["899932 (Hyperfoods)"],"award-info":[{"award-number":["899932 (Hyperfoods)"]}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["10058099"],"award-info":[{"award-number":["10058099"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["10058099"],"award-info":[{"award-number":["10058099"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["10058099"],"award-info":[{"award-number":["10058099"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["10058099"],"award-info":[{"award-number":["10058099"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["10058099"],"award-info":[{"award-number":["10058099"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101095359"],"award-info":[{"award-number":["101095359"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101095359"],"award-info":[{"award-number":["101095359"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101095359"],"award-info":[{"award-number":["101095359"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101095359"],"award-info":[{"award-number":["101095359"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["101095359"],"award-info":[{"award-number":["101095359"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008058","name":"Vodafone Foundation","doi-asserted-by":"publisher","award":["CORONA-AI\/DRUGS DreamLab"],"award-info":[{"award-number":["CORONA-AI\/DRUGS DreamLab"]}],"id":[{"id":"10.13039\/100008058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008058","name":"Vodafone Foundation","doi-asserted-by":"publisher","award":["CORONA-AI\/DRUGS DreamLab"],"award-info":[{"award-number":["CORONA-AI\/DRUGS DreamLab"]}],"id":[{"id":"10.13039\/100008058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008058","name":"Vodafone Foundation","doi-asserted-by":"publisher","award":["CORONA-AI\/DRUGS DreamLab"],"award-info":[{"award-number":["CORONA-AI\/DRUGS DreamLab"]}],"id":[{"id":"10.13039\/100008058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008058","name":"Vodafone Foundation","doi-asserted-by":"publisher","award":["CORONA-AI\/DRUGS DreamLab"],"award-info":[{"award-number":["CORONA-AI\/DRUGS DreamLab"]}],"id":[{"id":"10.13039\/100008058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008058","name":"Vodafone Foundation","doi-asserted-by":"publisher","award":["CORONA-AI\/DRUGS DreamLab"],"award-info":[{"award-number":["CORONA-AI\/DRUGS DreamLab"]}],"id":[{"id":"10.13039\/100008058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERC-Consolidator","award":["724228 (LEMAN)"],"award-info":[{"award-number":["724228 (LEMAN)"]}]},{"name":"ERC-Consolidator","award":["724228 (LEMAN)"],"award-info":[{"award-number":["724228 (LEMAN)"]}]},{"name":"ERC-Consolidator","award":["724228 (LEMAN)"],"award-info":[{"award-number":["724228 (LEMAN)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) poses a profound human, social, and economic burden. Previous studies suggest that extra virgin olive oil (EVOO) may be helpful in preventing cognitive decline. Here, we present a network machine learning method for identifying bioactive phytochemicals in EVOO with the highest potential to impact the protein network linked to the development and progression of the AD. A balanced classification accuracy of 70.3\u2009\u00b1\u20092.6% was achieved in fivefold cross-validation settings for predicting late-stage experimental drugs targeting AD from other clinically approved drugs. The calibrated machine learning algorithm was then used to predict the likelihood of existing drugs and known EVOO phytochemicals to be similar in action to the drugs impacting AD protein networks. These analyses identified the following ten EVOO phytochemicals with the highest likelihood of being active against AD: quercetin, genistein, luteolin, palmitoleate, stearic acid, apigenin, epicatechin, kaempferol, squalene, and daidzein (in the order from the highest to the lowest likelihood). This in silico study presents a framework that brings together artificial intelligence, analytical chemistry, and omics studies to identify unique therapeutic agents. It provides new insights into how EVOO constituents may help treat or prevent AD and potentially provide a basis for consideration in future clinical studies.<\/jats:p>","DOI":"10.1186\/s40246-023-00503-6","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T04:01:27Z","timestamp":1688702487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Alzheimer\u2019s disease: using gene\/protein network machine learning for molecule discovery in olive oil"],"prefix":"10.1186","volume":"17","author":[{"given":"Lu\u00eds","family":"Rita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie R.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Laponogov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Veselkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Pratico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Aalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos S.","family":"Thomaidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilis","family":"Vasiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Veselkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"503_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.31887\/DCNS.2019.21.1\/rperneczky","volume":"21","author":"R Perneczky","year":"2019","unstructured":"Perneczky R. Dementia treatment versus prevention. Dialogues Clin Neurosci. 2019;21:43\u201351.","journal-title":"Dialogues Clin Neurosci"},{"key":"503_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S1474-4422(16)30235-6","volume":"15","author":"H Shah","year":"2016","unstructured":"Shah H, Albanese E, Duggan C, Rudan I, Langa KM, Carrillo MC, et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 2016;15:1285\u201394.","journal-title":"Lancet Neurol"},{"key":"503_CR3","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/ana.20854","volume":"59","author":"N Scarmeas","year":"2006","unstructured":"Scarmeas N, Stern Y, Tang M-X, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer\u2019s disease. Ann Neurol. 2006;59:912\u201321.","journal-title":"Ann Neurol"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.neurol.2019.07.017","volume":"175","author":"GC Rom\u00e1n","year":"2019","unstructured":"Rom\u00e1n GC, Jackson RE, Reis J, Rom\u00e1n AN, Toledo JB, Toledo E. Extra-virgin olive oil for potential prevention of Alzheimer disease. Rev Neurol (Paris). 2019;175:705\u201323.","journal-title":"Rev Neurol (Paris)"},{"key":"503_CR5","volume-title":"Natural compounds as therapeutic agents for Amyloidogenic diseases","year":"2015","unstructured":"Vassallo N, editor. Natural compounds as therapeutic agents for Amyloidogenic diseases. Cham: Springer International Publishing; 2015."},{"key":"503_CR6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/jnnp-2012-304792","volume":"84","author":"EH Mart\u00ednez-Lapiscina","year":"2013","unstructured":"Mart\u00ednez-Lapiscina EH, Clavero P, Toledo E, Estruch R, Salas-Salvad\u00f3 J, San Juli\u00e1n B, et al. Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry. 2013;84:1318\u201325.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"23","key":"503_CR7","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.3390\/nu14235102","volume":"14","author":"A Kaddoumi","year":"2022","unstructured":"Kaddoumi A, Denney TS, Deshpande G, Robinson JL, Beyers RJ, Redden DT, et al. Extra-virgin olive oil enhances the blood-brain barrier function in mild cognitive impairment: a randomized controlled trial. Nutrients. 2022;14(23):5102.","journal-title":"Nutrients"},{"key":"503_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1001\/jamainternmed.2015.1668","volume":"175","author":"C Valls-Pedret","year":"2015","unstructured":"Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Mart\u00ednez-Gonz\u00e1lez M\u00c1, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med. 2015;175:1094\u2013103.","journal-title":"JAMA Intern Med"},{"key":"503_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-18365-7_1","volume":"863","author":"S Rigacci","year":"2015","unstructured":"Rigacci S. Olive oil phenols as promising multi-targeting agents against Alzheimer\u2019s disease. Adv Exp Med Biol. 2015;863:1\u201320.","journal-title":"Adv Exp Med Biol"},{"key":"503_CR10","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1021\/jm070559a","volume":"50","author":"ML Bolognesi","year":"2007","unstructured":"Bolognesi ML, Banzi R, Bartolini M, Cavalli A, Tarozzi A, Andrisano V, et al. Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer\u2019s disease. J Med Chem. 2007;50:4882\u201397.","journal-title":"J Med Chem"},{"key":"503_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, et al. A comprehensive map of molecular drug targets. Nat Rev Drug Discov. 2017;16:19\u201334.","journal-title":"Nat Rev Drug Discov"},{"key":"503_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","volume":"6","author":"J Gong","year":"2018","unstructured":"Gong J, Chehrazi-Raffle A, Reddi S, Salgia R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018;6:8.","journal-title":"J Immunother Cancer"},{"key":"503_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13321-020-00460-5","volume":"12","author":"L David","year":"2020","unstructured":"David L, Thakkar A, Mercado R, Engkvist O. Molecular representations in AI-driven drug discovery: a review and practical guide. J Cheminform. 2020;12:56.","journal-title":"J Cheminform"},{"key":"503_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrg.2017.38","volume":"18","author":"L Cowen","year":"2017","unstructured":"Cowen L, Ideker T, Raphael BJ, Sharan R. Network propagation: a universal amplifier of genetic associations. Nat Rev Genet. 2017;18:551\u201362.","journal-title":"Nat Rev Genet"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/s41467-021-21770-8","volume":"12","author":"C Ruiz","year":"2021","unstructured":"Ruiz C, Zitnik M, Leskovec J. Identification of disease treatment mechanisms through the multiscale interactome. Nat Commun. 2021;12:1796.","journal-title":"Nat Commun"},{"key":"503_CR16","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1038\/s41598-019-45349-y","volume":"9","author":"K Veselkov","year":"2019","unstructured":"Veselkov K, Gonzalez G, Aljifri S, Galea D, Mirnezami R, Youssef J, et al. HyperFoods: machine intelligent mapping of cancer-beating molecules in foods. Sci Rep. 2019;9:9237.","journal-title":"Sci Rep"},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40246-020-00297-x","volume":"15","author":"I Laponogov","year":"2021","unstructured":"Laponogov I, Gonzalez G, Shepherd M, Qureshi A, Veselkov D, Charkoftaki G, et al. Network machine learning maps phytochemically rich \u201cHyperfoods\u201d to fight COVID-19. Hum Genomics. 2021;15:1.","journal-title":"Hum Genomics"},{"key":"503_CR18","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587\u201392.","journal-title":"Nucleic Acids Res"},{"key":"503_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.cell.2011.02.016","volume":"144","author":"M Vidal","year":"2011","unstructured":"Vidal M, Cusick ME, Barab\u00e1si A-L. Interactome networks and human disease. Cell. 2011;144:986\u201398.","journal-title":"Cell"},{"key":"503_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/bioinformatics\/bty637","volume":"35","author":"A Valdeolivas","year":"2019","unstructured":"Valdeolivas A, Tichit L, Navarro C, Perrin S, Odelin G, Levy N, et al. Random walk with restart on multiplex and heterogeneous biological networks. Bioinformatics. 2019;35:497\u2013505.","journal-title":"Bioinformatics"},{"key":"503_CR21","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1016\/j.csbj.2021.05.015","volume":"19","author":"J Pi\u00f1ero","year":"2021","unstructured":"Pi\u00f1ero J, Sa\u00fcch J, Sanz F, Furlong LI. The DisGeNET cytoscape app: exploring and visualizing disease genomics data. Comput Struct Biotechnol J. 2021;19:2960\u20137.","journal-title":"Comput Struct Biotechnol J"},{"key":"503_CR22","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"A Bateman","year":"2021","unstructured":"Bateman A, Martin M-J, Orchard S, Magrane M, Agivetova R, Ahmad S, et al. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480\u20139.","journal-title":"Nucleic Acids Res"},{"key":"503_CR23","doi-asserted-by":"publisher","first-page":"D1138","DOI":"10.1093\/nar\/gkaa891","volume":"49","author":"AP Davis","year":"2021","unstructured":"Davis AP, Grondin CJ, Johnson RJ, Sciaky D, Wiegers J, Wiegers TC, et al. Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res. 2021;49:D1138\u201343.","journal-title":"Nucleic Acids Res"},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"e0170365","DOI":"10.1371\/journal.pone.0170365","volume":"12","author":"S Pavan","year":"2017","unstructured":"Pavan S, Rommel K, Mateo Marquina ME, H\u00f6hn S, Lanneau V, Rath A. Clinical practice guidelines for rare diseases: the orphanet database. PLoS ONE. 2017;12:e0170365.","journal-title":"PLoS ONE"},{"key":"503_CR25","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","volume":"372","author":"HL Rehm","year":"2015","unstructured":"Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen \u2014 the clinical genome resource. N Engl J Med. 2015;372:2235\u201342.","journal-title":"N Engl J Med"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Williams E, Foulger RE, Leigh S, Daugherty LC, Niblock O, et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet. 2019;51:1560\u20135.","journal-title":"Nat Genet"},{"key":"503_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13073-018-0531-8","volume":"10","author":"D Tamborero","year":"2018","unstructured":"Tamborero D, Rubio-Perez C, Deu-Pons J, Schroeder MP, Vivancos A, Rovira A, et al. Cancer genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med. 2018;10:25.","journal-title":"Genome Med"},{"key":"503_CR28","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/bioinformatics\/btv301","volume":"31","author":"A Guti\u00e9rrez-Sacrist\u00e1n","year":"2015","unstructured":"Guti\u00e9rrez-Sacrist\u00e1n A, Grosdidier S, Valverde O, Torrens M, Bravo \u00c0, Pi\u00f1ero J, et al. PsyGeNET: a knowledge platform on psychiatric disorders and their genes. Bioinformatics. 2015;31:3075\u20137.","journal-title":"Bioinformatics"},{"key":"503_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.foodchem.2018.02.101","volume":"256","author":"NP Kalogiouri","year":"2018","unstructured":"Kalogiouri NP, Aalizadeh R, Thomaidis NS. Application of an advanced and wide scope non-target screening workflow with LC-ESI-QTOF-MS and chemometrics for the classification of the greek olive oil varieties. Food Chem. 2018;256:53\u201361.","journal-title":"Food Chem"},{"key":"503_CR30","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.3390\/molecules25122919","volume":"25","author":"NP Kalogiouri","year":"2020","unstructured":"Kalogiouri NP, Aalizadeh R, Dasenaki ME, Thomaidis NS. Authentication of greek PDO kalamata table olives: a novel non-target high resolution mass spectrometric approach. Molecules. 2020;25:2919.","journal-title":"Molecules"},{"key":"503_CR31","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074\u201382.","journal-title":"Nucleic Acids Res"},{"key":"503_CR32","doi-asserted-by":"publisher","first-page":"D1276","DOI":"10.1093\/nar\/gkac1085","volume":"51","author":"S Avram","year":"2023","unstructured":"Avram S, Wilson TB, Curpan R, Halip L, Borota A, Bora A, et al. DrugCentral 2023 extends human clinical data and integrates veterinary drugs. Nucleic Acids Res. 2023;51:D1276\u201387.","journal-title":"Nucleic Acids Res"},{"key":"503_CR33","doi-asserted-by":"publisher","first-page":"e026652","DOI":"10.1136\/bmjopen-2018-026652","volume":"9","author":"RA Harrington","year":"2019","unstructured":"Harrington RA, Adhikari V, Rayner M, Scarborough P. Nutrient composition databases in the age of big data: foodDB, a comprehensive, real-time database infrastructure. BMJ Open. 2019;9:e026652.","journal-title":"BMJ Open"},{"key":"503_CR34","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","volume":"44","author":"D Szklarczyk","year":"2016","unstructured":"Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44:D380\u20134.","journal-title":"Nucleic Acids Res"},{"key":"503_CR35","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2012","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. 2012;12:2825.","journal-title":"J Mach Learn Res"},{"key":"503_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/bioinformatics\/btac757","volume":"39","author":"Z Fang","year":"2023","unstructured":"Fang Z, Liu X, Peltz G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics. 2023;39:757.","journal-title":"Bioinformatics"},{"key":"503_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jnutbio.2008.03.002","volume":"20","author":"MA Ansari","year":"2009","unstructured":"Ansari MA, Abdul HM, Joshi G, Opii WO, Butterfield DA. Protective effect of quercetin in primary neurons against Abeta(1\u201342): relevance to Alzheimer\u2019s disease. J Nutr Biochem. 2009;20:269\u201375.","journal-title":"J Nutr Biochem"},{"key":"503_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biom10010059","volume":"10","author":"H Khan","year":"2019","unstructured":"Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK. Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules. 2019;10:59.","journal-title":"Biomolecules"},{"key":"503_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lfs.2019.03.055","volume":"224","author":"E Zaplatic","year":"2019","unstructured":"Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K. Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease. Life Sci. 2019;224:109\u201319.","journal-title":"Life Sci"},{"key":"503_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fcell.2019.00197","volume":"7","author":"MS Uddin","year":"2019","unstructured":"Uddin MS, Kabir MT. Emerging signal regulating potential of genistein against Alzheimer\u2019s disease: a promising molecule of interest. Front Cell Dev Biol. 2019;7:197.","journal-title":"Front Cell Dev Biol"},{"key":"503_CR41","doi-asserted-by":"publisher","first-page":"7028","DOI":"10.1007\/s12035-016-0215-6","volume":"54","author":"KP Devi","year":"2017","unstructured":"Devi KP, Shanmuganathan B, Manayi A, Nabavi SF, Nabavi SM. Molecular and therapeutic targets of genistein in Alzheimer\u2019s disease. Mol Neurobiol. 2017;54:7028\u201341.","journal-title":"Mol Neurobiol"},{"key":"503_CR42","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.nlm.2010.12.001","volume":"95","author":"M Bagheri","year":"2011","unstructured":"Bagheri M, Joghataei M-T, Mohseni S, Roghani M. Genistein ameliorates learning and memory deficits in amyloid \u03b2(1\u201340) rat model of Alzheimer\u2019s disease. Neurobiol Learn Mem. 2011;95:270\u20136.","journal-title":"Neurobiol Learn Mem"},{"key":"503_CR43","doi-asserted-by":"publisher","first-page":"173S","DOI":"10.3945\/an.115.011130","volume":"8","author":"ME Frigolet","year":"2017","unstructured":"Frigolet ME, Guti\u00e9rrez-Aguilar R. The role of the novel lipokine palmitoleic acid in health and disease. Adv Nutr. 2017;8:173S-181S.","journal-title":"Adv Nutr"},{"key":"503_CR44","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.3390\/molecules18089949","volume":"18","author":"L Zhao","year":"2013","unstructured":"Zhao L, Wang J-L, Liu R, Li X-X, Li J-F, Zhang L. Neuroprotective, anti-amyloidogenic and neurotrophic effects of Apigenin in an Alzheimer\u2019s disease mouse model. Molecules. 2013;18:9949\u201365.","journal-title":"Molecules"},{"key":"503_CR45","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4103\/1673-5374.162686","volume":"10","author":"M Venigalla","year":"2015","unstructured":"Venigalla M, Sonego S, Gyengesi E, M\u00fcnch G. Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer\u2032s disease. Neural Regen Res. 2015;10:1181.","journal-title":"Neural Regen Res"},{"key":"503_CR46","doi-asserted-by":"publisher","first-page":"31450","DOI":"10.1038\/srep31450","volume":"6","author":"R Balez","year":"2016","unstructured":"Balez R, Steiner N, Engel M, Mu\u00f1oz SS, Lum JS, Wu Y, et al. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer\u2019s disease. Sci Rep. 2016;6:31450.","journal-title":"Sci Rep"},{"key":"503_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/JAD-122113","volume":"36","author":"RC George","year":"2013","unstructured":"George RC, Lew J, Graves DJ. Interaction of cinnamaldehyde and epicatechin with tau: implications of beneficial effects in modulating Alzheimer\u2019s disease pathogenesis. J Alzheimers Dis. 2013;36:21\u201340.","journal-title":"J Alzheimers Dis"},{"key":"503_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fneur.2014.00069","volume":"5","author":"Y-Q Zeng","year":"2014","unstructured":"Zeng Y-Q, Wang Y-J, Zhou X-F. Effects of (-)Epicatechin on the pathology of APP\/PS1 transgenic mice. Front Neurol. 2014;5:69.","journal-title":"Front Neurol"},{"issue":"6","key":"503_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/1871527317666180508123050","volume":"17","author":"T Beg","year":"2018","unstructured":"Beg T, Jyoti S, Naz F, Ali F, Ali SK, Reyad AM, Siddique YH. Protective effect of Kaempferol on the transgenic drosophila model of Alzheimer\u2019s disease. CNS Neurol Disord-Drug. 2018;17(6):421\u20139.","journal-title":"CNS Neurol Disord-Drug"},{"key":"503_CR50","doi-asserted-by":"crossref","unstructured":"Silva dos Santos J, Gon\u00e7alves Cirino JP, de Oliveira Carvalho P, Ortega MM. The pharmacological action of Kaempferol in Central nervous system diseases: a review. Front Pharmacol 2021;11: 565700.","DOI":"10.3389\/fphar.2020.565700"},{"key":"503_CR51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12603-011-0140-3","volume":"16","author":"M Pan","year":"2012","unstructured":"Pan M, Han H, Zhong C, Geng Q. Effects of genistein and daidzein on hippocampus neuronal cell proliferation and BDNF expression in H19\u20137 neural cell line. J Nutr Health Aging. 2012;16:389\u201394.","journal-title":"J Nutr Health Aging"},{"key":"503_CR52","first-page":"1","volume":"2013","author":"RCY Choi","year":"2013","unstructured":"Choi RCY, Zhu JTT, Yung AWY, Lee PSC, Xu SL, Guo AJY, et al. Synergistic action of flavonoids, Baicalein, and Daidzein in estrogenic and neuroprotective effects: a development of potential health products and therapeutic drugs against Alzheimer\u2019s disease. Evid Based Complement Altern Med. 2013;2013:1\u201310.","journal-title":"Evid Based Complement Altern Med"},{"key":"503_CR53","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.neuroscience.2011.12.002","volume":"202","author":"S Snigdha","year":"2012","unstructured":"Snigdha S, Astarita G, Piomelli D, Cotman CW. Effects of diet and behavioral enrichment on free fatty acids in the aged canine brain. Neuroscience. 2012;202:326\u201333.","journal-title":"Neuroscience"},{"key":"503_CR54","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.arr.2020.101043","volume":"60","author":"M Hosseini","year":"2020","unstructured":"Hosseini M, Poljak A, Braidy N, Crawford J, Sachdev P. Blood fatty acids in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review. Ageing Res Rev. 2020;60:101043.","journal-title":"Ageing Res Rev"},{"key":"503_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12017-020-08636-w","volume":"23","author":"Y Otoki","year":"2021","unstructured":"Otoki Y, Kato S, Nakagawa K, Harvey DJ, Jin L-W, Dugger BN, et al. Lipidomic analysis of postmortem prefrontal cortex phospholipids reveals changes in choline plasmalogen containing Docosahexaenoic acid and stearic acid between cases with and without Alzheimer\u2019s disease. Neuromolecular Med. 2021;23:161\u201375.","journal-title":"Neuromolecular Med"},{"key":"503_CR56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11064-009-0087-5","volume":"35","author":"T Fraser","year":"2010","unstructured":"Fraser T, Tayler H, Love S. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer\u2019s disease. Neurochem Res. 2010;35:503\u201313.","journal-title":"Neurochem Res"},{"key":"503_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41514-021-00064-9","volume":"7","author":"VR Varma","year":"2021","unstructured":"Varma VR, B\u00fc\u015fra L\u00fcleci H, Oommen AM, Varma S, Blackshear CT, Griswold ME, et al. Abnormal brain cholesterol homeostasis in Alzheimer\u2019s disease\u2014a targeted metabolomic and transcriptomic study. NPJ Aging Mech Dis. 2021;7:11.","journal-title":"NPJ Aging Mech Dis"},{"key":"503_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1567205014666170505101426","volume":"15","author":"A Zarrouk","year":"2018","unstructured":"Zarrouk A, Debbabi M, Bezine M, Karym EM, Badreddine A, Rouaud O, et al. Lipid biomarkers in Alzheimer\u2019s disease. Curr Alzheimer Res. 2018;15:303\u201312.","journal-title":"Curr Alzheimer Res"},{"key":"503_CR59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12035-013-8627-z","volume":"50","author":"DA Hottman","year":"2014","unstructured":"Hottman DA, Li L. Protein prenylation and synaptic plasticity: implications for Alzheimer\u2019s disease. Mol Neurobiol. 2014;50:177\u201385.","journal-title":"Mol Neurobiol"},{"key":"503_CR60","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1176\/appi.ajp.157.9.1399","volume":"157","author":"DP Devanand","year":"2000","unstructured":"Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer\u2019s disease at follow-up. Am J Psychiatry. 2000;157:1399\u2013405.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"503_CR61","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1749-6632.1998.tb10654.x","volume":"855","author":"C Murphy","year":"1998","unstructured":"Murphy C, Bacon AW, Bondi MW, Salmon DP. Apolipoprotein E status is associated with Odor identification deficits in nondemented older persons. Ann NY Acad Sci. 1998;855(1):744\u201350.","journal-title":"Ann NY Acad Sci"},{"key":"503_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1212\/WNL.0000000000001132","volume":"84","author":"DP Devanand","year":"2015","unstructured":"Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Doty RL, et al. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community. Neurology. 2015;84:182\u20139.","journal-title":"Neurology"},{"key":"503_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1523\/JNEUROSCI.4622-09.2010","volume":"30","author":"DW Wesson","year":"2010","unstructured":"Wesson DW, Levy E, Nixon RA, Wilson DA. Olfactory dysfunction correlates with amyloid-\u03b2 burden in an Alzheimer\u2019s disease mouse model. J Neurosci. 2010;30:505\u201314.","journal-title":"J Neurosci"},{"key":"503_CR64","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2","author":"SM de la Monte","year":"2008","unstructured":"de la Monte SM, Wands JR. Alzheimer\u2019s disease is type 3 diabetes\u2014evidence reviewed. J Diabetes Sci Technol. 2008;2:1101\u201313.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"503_CR65","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nn.2100","volume":"11","author":"DE Berman","year":"2008","unstructured":"Berman DE, Dall\u2019Armi C, Voronov SV, McIntire LB, Zhang H, Moore AZ, Staniszewski A, Arancio O, Kim TW, Di Paolo G. Oligomeric amyloid-\u03b2 peptide disrupts phosphatidylinositol-4, 5-bisphosphate metabolism. Nat Neurosci. 2008;11(5):547\u201354.","journal-title":"Nat Neurosci"},{"key":"503_CR66","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat Rev Neurosci. 2004;5:347\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"503_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-023-00503-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-023-00503-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-023-00503-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T05:03:12Z","timestamp":1688706192000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-023-00503-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/s40246-023-00503-6","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs Vasiliou, Veselkov, and Thomaidis are serving as Editors for the Journal of Human Genomics and will exclude themselves from the review process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}